NASDAQ / LIVE COMPANY INTELLIGENCE

Drugs Made In America Acquisition Corp.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERDMAA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / DMAA COVERAGE

What’s moving Drugs Made In America Acquisition Corp. now

Current reporting with the operating signal separated from the noise.

01
Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp.

The story matters when it changes Drugs Made In America Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest DMAA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-18 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-04-15 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-20 · Period 2026-07-14SEC ↗8-KMaterial company eventFiled 2026-05-05 · Period 2026-04-29SEC ↗8-KMaterial company eventFiled 2026-05-01 · Period 2026-04-27SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-14 · Period 2026-04-27SEC ↗425Official SEC filingFiled 2026-07-20SEC ↗
EARNINGS / QUARTERLY TRACKER

Drugs Made In America Acquisition Corp., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.